Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML.

Velasco-Hernandez T, Soneji S, Hidalgo I, Erlandsson E, Cammenga J, Bryder D.

Stem Cell Reports. 2019 Jan 8;12(1):112-121. doi: 10.1016/j.stemcr.2018.11.023. Epub 2018 Dec 27.

2.

Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging.

Säwen P, Eldeeb M, Erlandsson E, Kristiansen TA, Laterza C, Kokaia Z, Karlsson G, Yuan J, Soneji S, Mandal PK, Rossi DJ, Bryder D.

Elife. 2018 Dec 18;7. pii: e41258. doi: 10.7554/eLife.41258.

3.

Author Correction: Rapid and efficient induction of functional astrocytes from human pluripotent stem cells.

Canals I, Ginisty A, Quist E, Timmerman R, Fritze J, Miskinyte G, Monni E, Hansen MG, Hidalgo I, Bryder D, Bengzon J, Ahlenius H.

Nat Methods. 2019 Jan;16(1):134. doi: 10.1038/s41592-018-0264-z.

PMID:
30514884
4.

Immunoediting is not a primary transformation event in a murine model of MLL-ENL AML.

Dudenhöffer-Pfeifer M, Bryder D.

Life Sci Alliance. 2018 Jul 10;1(4):e201800079. doi: 10.26508/lsa.201800079. eCollection 2018 Aug.

5.

Rapid and efficient induction of functional astrocytes from human pluripotent stem cells.

Canals I, Ginisty A, Quist E, Timmerman R, Fritze J, Miskinyte G, Monni E, Hansen MG, Hidalgo I, Bryder D, Bengzon J, Ahlenius H.

Nat Methods. 2018 Sep;15(9):693-696. doi: 10.1038/s41592-018-0103-2. Epub 2018 Aug 20. Erratum in: Nat Methods. 2019 Jan;16(1):134.

PMID:
30127505
6.

Dissection of progenitor compartments resolves developmental trajectories in B-lymphopoiesis.

Jensen CT, Åhsberg J, Sommarin MNE, Strid T, Somasundaram R, Okuyama K, Ungerbäck J, Kupari J, Airaksinen MS, Lang S, Bryder D, Soneji S, Karlsson G, Sigvardsson M.

J Exp Med. 2018 Jul 2;215(7):1947-1963. doi: 10.1084/jem.20171384. Epub 2018 Jun 13.

7.

SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

Davidsson J, Puschmann A, Tedgård U, Bryder D, Nilsson L, Cammenga J.

Leukemia. 2018 May;32(5):1106-1115. doi: 10.1038/s41375-018-0074-4. Epub 2018 Feb 25. Review.

8.

Hepatic Leukemia Factor Maintains Quiescence of Hematopoietic Stem Cells and Protects the Stem Cell Pool during Regeneration.

Komorowska K, Doyle A, Wahlestedt M, Subramaniam A, Debnath S, Chen J, Soneji S, Van Handel B, Mikkola HKA, Miharada K, Bryder D, Larsson J, Magnusson M.

Cell Rep. 2017 Dec 19;21(12):3514-3523. doi: 10.1016/j.celrep.2017.11.084.

9.

Critical Modulation of Hematopoietic Lineage Fate by Hepatic Leukemia Factor.

Wahlestedt M, Ladopoulos V, Hidalgo I, Sanchez Castillo M, Hannah R, Säwén P, Wan H, Dudenhöffer-Pfeifer M, Magnusson M, Norddahl GL, Göttgens B, Bryder D.

Cell Rep. 2017 Nov 21;21(8):2251-2263. doi: 10.1016/j.celrep.2017.10.112.

10.

Immunophenotypic Identification of Early Myeloerythroid Development.

Pronk CJH, Bryder D.

Methods Mol Biol. 2018;1678:301-319. doi: 10.1007/978-1-4939-7346-0_13.

PMID:
29071684
11.

The slippery slope of hematopoietic stem cell aging.

Wahlestedt M, Bryder D.

Exp Hematol. 2017 Dec;56:1-6. doi: 10.1016/j.exphem.2017.09.008. Epub 2017 Sep 21. Review.

PMID:
28943295
12.

ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.

Garrison BS, Rybak AP, Beerman I, Heesters B, Mercier FE, Scadden DT, Bryder D, Baron R, Rossi DJ.

Blood. 2017 Aug 3;130(5):619-624. doi: 10.1182/blood-2016-09-738591. Epub 2017 Jun 14.

13.

Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate.

Wahlestedt M, Erlandsson E, Kristiansen T, Lu R, Brakebusch C, Weissman IL, Yuan J, Martin-Gonzalez J, Bryder D.

Nat Commun. 2017 Feb 22;8:14533. doi: 10.1038/ncomms14533.

14.

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

Tesi B, Davidsson J, Voss M, Rahikkala E, Holmes TD, Chiang SCC, Komulainen-Ebrahim J, Gorcenco S, Rundberg Nilsson A, Ripperger T, Kokkonen H, Bryder D, Fioretos T, Henter JI, Möttönen M, Niinimäki R, Nilsson L, Pronk CJ, Puschmann A, Qian H, Uusimaa J, Moilanen J, Tedgård U, Cammenga J, Bryceson YT.

Blood. 2017 Apr 20;129(16):2266-2279. doi: 10.1182/blood-2016-10-743302. Epub 2017 Feb 15.

15.

Molecular mechanisms underlying lineage bias in aging hematopoiesis.

Elias HK, Bryder D, Park CY.

Semin Hematol. 2017 Jan;54(1):4-11. doi: 10.1053/j.seminhematol.2016.11.002. Epub 2016 Nov 20. Review.

PMID:
28088987
16.

MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.

Ugale A, Säwén P, Dudenhöffer-Pfeifer M, Wahlestedt M, Norddahl GL, Bryder D.

Oncogene. 2017 Jun 1;36(22):3207-3212. doi: 10.1038/onc.2016.470. Epub 2017 Jan 9.

PMID:
28068328
17.

Hematopoiesis at single-cell resolution.

Bryder D.

Blood. 2016 Aug 25;128(8):1025-6. doi: 10.1182/blood-2016-07-726497. No abstract available.

18.

Cellular Barcoding Links B-1a B Cell Potential to a Fetal Hematopoietic Stem Cell State at the Single-Cell Level.

Kristiansen TA, Jaensson Gyllenbäck E, Zriwil A, Björklund T, Daniel JA, Sitnicka E, Soneji S, Bryder D, Yuan J.

Immunity. 2016 Aug 16;45(2):346-57. doi: 10.1016/j.immuni.2016.07.014.

19.

Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis.

Velasco-Hernandez T, Säwén P, Bryder D, Cammenga J.

Stem Cell Reports. 2016 Jul 12;7(1):11-8. doi: 10.1016/j.stemcr.2016.06.002. Epub 2016 Jun 30.

20.

Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias.

Rundberg Nilsson A, Soneji S, Adolfsson S, Bryder D, Pronk CJ.

PLoS One. 2016 Jul 1;11(7):e0158369. doi: 10.1371/journal.pone.0158369. eCollection 2016.

Supplemental Content

Loading ...
Support Center